25 XP   0   0   10

Henan Lingrui Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Lingrui together

PenkeI guess you are interested in Henan Lingrui Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Henan Lingrui Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Henan Lingrui Pharmaceutical Co Ltd

I send you an email if I find something interesting about Henan Lingrui Pharmaceutical Co Ltd.

Quick analysis of Lingrui (30 sec.)










What can you expect buying and holding a share of Lingrui? (30 sec.)

How much money do you get?

How much money do you get?
¥0.25
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.79
Expected worth in 1 year
¥5.26
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
¥2.25
Return On Investment
10.6%

For what price can you sell your share?

Current Price per Share
¥21.28
Expected price per share
¥18.27 - ¥21.73
How sure are you?
50%

1. Valuation of Lingrui (5 min.)




Live pricePrice per Share (EOD)

¥21.28

Intrinsic Value Per Share

¥3.35 - ¥14.68

Total Value Per Share

¥8.14 - ¥19.48

2. Growth of Lingrui (5 min.)




Is Lingrui growing?

Current yearPrevious yearGrowGrow %
How rich?$376.2m$327.6m$36.8m10.1%

How much money is Lingrui making?

Current yearPrevious yearGrowGrow %
Making money$18.2m$15.2m$2.9m16.3%
Net Profit Margin16.0%14.8%--

How much money comes from the company's main activities?

3. Financial Health of Lingrui (5 min.)




What can you expect buying and holding a share of Lingrui? (5 min.)

Welcome investor! Lingrui's management wants to use your money to grow the business. In return you get a share of Lingrui.

What can you expect buying and holding a share of Lingrui?

First you should know what it really means to hold a share of Lingrui. And how you can make/lose money.

Speculation

The Price per Share of Lingrui is ¥21.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lingrui.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lingrui, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.79. Based on the TTM, the Book Value Change Per Share is ¥0.12 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.44 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lingrui.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.040.2%0.040.2%0.030.1%0.030.1%0.020.1%
Usd Book Value Change Per Share0.040.2%0.020.1%0.010.1%0.010.0%0.010.1%
Usd Dividend Per Share0.000.0%0.060.3%0.020.1%0.020.1%0.020.1%
Usd Total Gains Per Share0.040.2%0.080.4%0.030.1%0.030.1%0.030.1%
Usd Price Per Share2.48-2.16-1.84-1.56-1.52-
Price to Earnings Ratio17.02-13.41-25.91-19.12-37.19-
Price-to-Total Gains Ratio59.98-36.37-96.18--15.64-36.06-
Price to Book Ratio3.74-3.36-3.19-2.70-3.14-
Price-to-Total Gains Ratio59.98-36.37-96.18--15.64-36.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.945152
Number of shares339
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.02
Usd Book Value Change Per Share0.020.01
Usd Total Gains Per Share0.080.03
Gains per Quarter (339 shares)26.349.87
Gains per Year (339 shares)105.3839.48
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1832295301029
216744200592068
3250663058929107
43338841011939146
541711051514849185
650013262017859224
758315472520869263
866717683023778302
975019993526788341
10833221104029798380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%86.00.01.098.9%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%13.07.00.065.0%25.015.00.062.5%58.029.00.066.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%66.00.021.075.9%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%32.08.00.080.0%72.015.00.082.8%

Fundamentals of Lingrui

About Henan Lingrui Pharmaceutical Co Ltd

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

Fundamental data was last updated by Penke on 2024-03-26 16:19:09.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Henan Lingrui Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lingrui earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 18.5% means that ¥0.19 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 18.5%. The company is making a huge profit. +2
  • The TTM is 16.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.5%TTM16.0%+2.5%
TTM16.0%YOY14.8%+1.2%
TTM16.0%5Y14.3%+1.7%
5Y14.3%10Y14.1%+0.2%
1.1.2. Return on Assets

Shows how efficient Lingrui is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.2% Return on Assets means that Lingrui generated ¥0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 3.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.9%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.2%TTM2.9%+0.3%
TTM2.9%YOY2.7%+0.2%
TTM2.9%5Y2.5%+0.4%
5Y2.5%10Y2.1%+0.4%
1.1.3. Return on Equity

Shows how efficient Lingrui is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.5% Return on Equity means Lingrui generated ¥0.06 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 5.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.5%TTM5.0%+0.5%
TTM5.0%YOY4.6%+0.4%
TTM5.0%5Y4.1%+0.9%
5Y4.1%10Y3.4%+0.7%

1.2. Operating Efficiency of Henan Lingrui Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lingrui is operating .

  • Measures how much profit Lingrui makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.9%-4.9%
TTM4.9%YOY13.7%-8.9%
TTM4.9%5Y12.6%-7.8%
5Y12.6%10Y7.0%+5.6%
1.2.2. Operating Ratio

Measures how efficient Lingrui is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.07 means that the operating costs are ¥1.07 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 1.069. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.099. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.069TTM1.099-0.030
TTM1.099YOY1.124-0.025
TTM1.0995Y1.095+0.004
5Y1.09510Y0.747+0.348

1.3. Liquidity of Henan Lingrui Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lingrui is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.33 means the company has ¥1.33 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 1.331. The company is just able to pay all its short-term debts.
  • The TTM is 1.427. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.331TTM1.427-0.096
TTM1.427YOY1.445-0.018
TTM1.4275Y1.577-0.150
5Y1.57710Y0.865+0.712
1.3.2. Quick Ratio

Measures if Lingrui is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.16 means the company can pay off ¥0.16 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 0.160. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.192. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.160TTM0.192-0.031
TTM0.192YOY0.470-0.278
TTM0.1925Y0.458-0.266
5Y0.45810Y0.431+0.027

1.4. Solvency of Henan Lingrui Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lingrui assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lingrui to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.41 means that Lingrui assets are financed with 41.3% credit (debt) and the remaining percentage (100% - 41.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 0.413. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.409. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.413TTM0.409+0.004
TTM0.409YOY0.405+0.004
TTM0.4095Y0.374+0.034
5Y0.37410Y0.366+0.008
1.4.2. Debt to Equity Ratio

Measures if Lingrui is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 70.6% means that company has ¥0.71 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The MRQ is 0.706. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.693. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.706TTM0.693+0.012
TTM0.693YOY0.684+0.010
TTM0.6935Y0.605+0.089
5Y0.60510Y0.588+0.017

2. Market Valuation of Henan Lingrui Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Lingrui generates.

  • Above 15 is considered overpriced but always compare Lingrui to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 17.02 means the investor is paying ¥17.02 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The EOD is 20.222. Based on the earnings, the company is fair priced.
  • The MRQ is 17.020. Based on the earnings, the company is fair priced.
  • The TTM is 13.413. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.222MRQ17.020+3.203
MRQ17.020TTM13.413+3.606
TTM13.413YOY25.910-12.496
TTM13.4135Y19.116-5.702
5Y19.11610Y37.195-18.079
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The EOD is 26.605. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 22.391. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 16.145. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD26.605MRQ22.391+4.213
MRQ22.391TTM16.145+6.247
TTM16.145YOY13.440+2.705
TTM16.1455Y13.740+2.405
5Y13.74010Y11.033+2.707
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lingrui is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Henan Lingrui Pharmaceutical Co Ltd:

  • The EOD is 4.439. Based on the equity, the company is fair priced.
  • The MRQ is 3.736. Based on the equity, the company is fair priced.
  • The TTM is 3.363. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.439MRQ3.736+0.703
MRQ3.736TTM3.363+0.373
TTM3.363YOY3.194+0.170
TTM3.3635Y2.696+0.668
5Y2.69610Y3.140-0.445
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Henan Lingrui Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2980.118+154%0.090+232%0.052+471%0.077+287%
Book Value Per Share--4.7944.642+3%4.171+15%4.136+16%3.670+31%
Current Ratio--1.3311.427-7%1.445-8%1.577-16%0.865+54%
Debt To Asset Ratio--0.4130.409+1%0.405+2%0.374+10%0.366+13%
Debt To Equity Ratio--0.7060.693+2%0.684+3%0.605+17%0.588+20%
Dividend Per Share--0.0000.444-100%0.124-100%0.158-100%0.120-100%
Eps--0.2630.294-11%0.194+36%0.184+43%0.136+94%
Free Cash Flow Per Share--0.2000.373-46%0.288-31%0.259-23%0.114+75%
Free Cash Flow To Equity Per Share--0.200-0.031+115%0.157+27%0.058+245%0.037+443%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--14.683--------
Intrinsic Value_10Y_min--3.348--------
Intrinsic Value_1Y_max--1.302--------
Intrinsic Value_1Y_min--0.440--------
Intrinsic Value_3Y_max--4.041--------
Intrinsic Value_3Y_min--1.239--------
Intrinsic Value_5Y_max--6.935--------
Intrinsic Value_5Y_min--1.941--------
Market Cap12068824320.000+16%10157549040.0008867334030.600+15%7534203118.800+35%6384273998.328+59%6215581663.164+63%
Net Profit Margin--0.1850.160+16%0.148+25%0.143+29%0.141+31%
Operating Margin---0.049-100%0.137-100%0.126-100%0.070-100%
Operating Ratio--1.0691.099-3%1.124-5%1.095-2%0.747+43%
Pb Ratio4.439+16%3.7363.363+11%3.194+17%2.696+39%3.140+19%
Pe Ratio20.222+16%17.02013.413+27%25.910-34%19.116-11%37.195-54%
Price Per Share21.280+16%17.91015.630+15%13.275+35%11.250+59%10.956+63%
Price To Free Cash Flow Ratio26.605+16%22.39116.145+39%13.440+67%13.740+63%11.033+103%
Price To Total Gains Ratio71.266+16%59.98036.371+65%96.182-38%-15.642+126%36.058+66%
Quick Ratio--0.1600.192-16%0.470-66%0.458-65%0.431-63%
Return On Assets--0.0320.029+9%0.027+18%0.025+27%0.021+53%
Return On Equity--0.0550.050+10%0.046+19%0.041+34%0.034+63%
Total Gains Per Share--0.2990.562-47%0.214+39%0.210+42%0.197+51%
Usd Book Value--376273326.372364472087.429+3%327649403.340+15%324834211.410+16%288140535.819+31%
Usd Book Value Change Per Share--0.0410.016+154%0.012+232%0.007+471%0.011+287%
Usd Book Value Per Share--0.6630.642+3%0.577+15%0.572+16%0.508+31%
Usd Dividend Per Share--0.0000.061-100%0.017-100%0.022-100%0.017-100%
Usd Eps--0.0360.041-11%0.027+36%0.025+43%0.019+94%
Usd Free Cash Flow--15695790.06229300294.741-46%22629112.102-31%20375086.790-23%8091679.504+94%
Usd Free Cash Flow Per Share--0.0280.052-46%0.040-31%0.036-23%0.016+75%
Usd Free Cash Flow To Equity Per Share--0.028-0.004+115%0.022+27%0.008+245%0.005+443%
Usd Market Cap1670325285.888+16%1405804787.1361227239029.835+15%1042733711.642+35%883583521.369+59%860236502.182+63%
Usd Price Per Share2.945+16%2.4792.163+15%1.837+35%1.557+59%1.516+63%
Usd Profit--20649409.54118205397.821+13%15229395.459+36%13448807.779+54%10172888.722+103%
Usd Revenue--111566777.964111814001.1190%100945333.984+11%90991545.979+23%69524428.810+60%
Usd Total Gains Per Share--0.0410.078-47%0.030+39%0.029+42%0.027+51%
 EOD+4 -4MRQTTM+16 -19YOY+21 -145Y+22 -1310Y+25 -10

3.2. Fundamental Score

Let's check the fundamental score of Henan Lingrui Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.222
Price to Book Ratio (EOD)Between0-14.439
Net Profit Margin (MRQ)Greater than00.185
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.160
Current Ratio (MRQ)Greater than11.331
Debt to Asset Ratio (MRQ)Less than10.413
Debt to Equity Ratio (MRQ)Less than10.706
Return on Equity (MRQ)Greater than0.150.055
Return on Assets (MRQ)Greater than0.050.032
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Henan Lingrui Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.271
Ma 20Greater thanMa 5020.846
Ma 50Greater thanMa 10019.143
Ma 100Greater thanMa 20017.981
OpenGreater thanClose20.860
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,632,078
Total Liabilities1,913,340
Total Stockholder Equity2,711,118
 As reported
Total Liabilities 1,913,340
Total Stockholder Equity+ 2,711,118
Total Assets = 4,632,078

Assets

Total Assets4,632,078
Total Current Assets2,446,359
Long-term Assets2,185,719
Total Current Assets
Cash And Cash Equivalents 1,217,827
Short-term Investments 202
Net Receivables 294,828
Inventory 454,613
Other Current Assets 96,494
Total Current Assets  (as reported)2,446,359
Total Current Assets  (calculated)2,063,966
+/- 382,393
Long-term Assets
Property Plant Equipment 659,548
Intangible Assets 241,937
Long-term Assets Other 717,176
Long-term Assets  (as reported)2,185,719
Long-term Assets  (calculated)1,618,661
+/- 567,058

Liabilities & Shareholders' Equity

Total Current Liabilities1,838,326
Long-term Liabilities75,014
Total Stockholder Equity2,711,118
Total Current Liabilities
Short Long Term Debt 101,787
Accounts payable 74,955
Other Current Liabilities 40,923
Total Current Liabilities  (as reported)1,838,326
Total Current Liabilities  (calculated)217,665
+/- 1,620,660
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,135
Long-term Liabilities  (as reported)75,014
Long-term Liabilities  (calculated)6,135
+/- 68,879
Total Stockholder Equity
Retained Earnings 1,508,409
Total Stockholder Equity (as reported)2,711,118
Total Stockholder Equity (calculated)1,508,409
+/- 1,202,708
Other
Capital Stock567,144
Common Stock Shares Outstanding 567,144
Net Invested Capital 2,812,905
Net Working Capital 608,033
Property Plant and Equipment Gross 659,548



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
174,355
514,794
534,890
560,377
539,335
570,966
598,160
697,745
655,784
746,433
734,945
741,336
800,680
835,569
857,367
828,814
870,272
881,367
890,543
872,235
886,118
958,713
918,306
878,693
1,032,687
970,371
1,055,471
942,551
980,875
982,819
982,260
968,269
1,033,039
1,048,681
1,032,425
1,024,204
1,081,913
1,115,245
1,181,408
1,198,939
1,261,039
1,234,818
1,230,510
1,208,031
1,248,670
1,259,163
1,302,117
1,294,324
1,494,575
1,477,761
1,594,673
1,648,124
1,721,901
1,763,907
2,379,940
2,474,453
2,909,672
2,835,680
2,606,389
2,708,629
2,616,024
3,107,478
3,068,886
2,981,521
3,201,286
3,212,360
3,299,397
3,307,565
3,511,170
3,439,251
3,362,546
3,109,964
3,452,359
3,525,724
3,451,099
3,315,778
3,517,218
3,347,481
3,380,280
3,457,756
3,770,058
3,607,580
3,715,556
3,793,087
4,055,163
3,969,775
4,101,140
4,344,383
4,491,462
4,345,871
4,632,078
4,632,0784,345,8714,491,4624,344,3834,101,1403,969,7754,055,1633,793,0873,715,5563,607,5803,770,0583,457,7563,380,2803,347,4813,517,2183,315,7783,451,0993,525,7243,452,3593,109,9643,362,5463,439,2513,511,1703,307,5653,299,3973,212,3603,201,2862,981,5213,068,8863,107,4782,616,0242,708,6292,606,3892,835,6802,909,6722,474,4532,379,9401,763,9071,721,9011,648,1241,594,6731,477,7611,494,5751,294,3241,302,1171,259,1631,248,6701,208,0311,230,5101,234,8181,261,0391,198,9391,181,4081,115,2451,081,9131,024,2041,032,4251,048,6811,033,039968,269982,260982,819980,875942,5511,055,471970,3711,032,687878,693918,306958,713886,118872,235890,543881,367870,272828,814857,367835,569800,680741,336734,945746,433655,784697,745598,160570,966539,335560,377534,890514,794174,355
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,855,122
1,818,113
1,594,808
1,869,087
1,908,806
1,828,324
1,754,361
1,976,255
1,822,015
1,878,064
1,916,541
2,191,108
2,011,023
2,137,750
2,131,237
2,178,915
2,213,494
2,388,498
2,508,393
2,594,576
2,390,809
2,446,359
2,446,3592,390,8092,594,5762,508,3932,388,4982,213,4942,178,9152,131,2372,137,7502,011,0232,191,1081,916,5411,878,0641,822,0151,976,2551,754,3611,828,3241,908,8061,869,0871,594,8081,818,1131,855,122000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
597,114
760,878
640,026
801,249
800,210
725,185
741,211
773,822
711,109
775,172
732,317
1,059,501
843,950
929,603
801,242
753,704
954,057
1,121,151
1,179,296
1,421,284
1,306,257
1,217,827
1,217,8271,306,2571,421,2841,179,2961,121,151954,057753,704801,242929,603843,9501,059,501732,317775,172711,109773,822741,211725,185800,210801,249640,026760,878597,114000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137,200
0
31,200
3,339
63,859
43,626
27,826
221,552
36,116
40,778
57,232
3,522
514
295
280,194
250,206
30,243
50,375
150,421
185
181
202
202181185150,42150,37530,243250,206280,1942955143,52257,23240,77836,116221,55227,82643,62663,8593,33931,2000137,200000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
61,739
71,040
107,383
83,517
86,328
84,642
89,097
84,774
104,601
107,900
128,627
120,905
193,689
184,779
226,531
146,496
162,409
158,816
160,677
159,448
169,719
183,598
194,210
188,767
227,339
218,644
257,714
214,273
244,774
249,691
273,412
213,187
200,327
231,943
207,562
171,226
206,589
209,762
241,828
196,069
197,132
248,954
238,348
127,559
153,789
158,870
178,399
146,777
191,490
179,061
213,273
175,413
205,608
217,963
229,869
159,141
234,135
212,681
241,534
187,673
257,235
307,665
319,004
338,506
399,305
553,429
582,986
577,211
670,479
713,358
620,304
567,014
245,369
318,497
311,135
662,953
647,032
722,457
732,621
717,134
687,537
605,613
577,162
440,767
547,420
640,470
653,037
195,973
211,930
481,551
294,828
294,828481,551211,930195,973653,037640,470547,420440,767577,162605,613687,537717,134732,621722,457647,032662,953311,135318,497245,369567,014620,304713,358670,479577,211582,986553,429399,305338,506319,004307,665257,235187,673241,534212,681234,135159,141229,869217,963205,608175,413213,273179,061191,490146,777178,399158,870153,789127,559238,348248,954197,132196,069241,828209,762206,589171,226207,562231,943200,327213,187273,412249,691244,774214,273257,714218,644227,339188,767194,210183,598169,719159,448160,677158,816162,409146,496226,531184,779193,689120,905128,627107,900104,60184,77489,09784,64286,32883,517107,38371,04061,739
       Other Current Assets 
7,098
8,194
13,093
22,784
23,973
20,615
18,889
7,909
13,082
18,207
23,503
9,600
12,220
22,959
23,960
22,040
22,923
22,211
25,627
20,193
28,893
42,544
48,891
24,073
29,514
35,454
42,756
26,855
42,854
22,614
20,154
35,967
54,864
22,157
16,666
12,500
27,345
20,968
30,369
23,521
30,170
23,931
29,856
21,668
27,916
19,113
31,816
29,850
26,731
53,938
60,578
52,258
20,630
68,153
14,556
16,762
27,310
20,462
52,225
16,911
70,940
19,687
446,896
28,780
361,671
41,228
340,855
29,553
209,489
34,839
71,707
24,004
67,051
410
206
35,690
31,237
55,132
32,345
38,361
104,517
38,720
241,144
39,866
175,726
22,459
133,539
131,851
104,789
27,690
96,494
96,49427,690104,789131,851133,53922,459175,72639,866241,14438,720104,51738,36132,34555,13231,23735,69020641067,05124,00471,70734,839209,48929,553340,85541,228361,67128,780446,89619,68770,94016,91152,22520,46227,31016,76214,55668,15320,63052,25860,57853,93826,73129,85031,81619,11327,91621,66829,85623,93130,17023,52130,36920,96827,34512,50016,66622,15754,86435,96720,15422,61442,85426,85542,75635,45429,51424,07348,89142,54428,89320,19325,62722,21122,92322,04023,96022,95912,2209,60023,50318,20713,0827,90918,88920,61523,97322,78413,0938,1947,098
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,583,272
1,616,917
1,622,775
1,561,417
1,540,963
1,525,466
1,502,216
1,541,216
1,578,950
1,596,557
1,577,806
1,661,850
1,876,248
1,756,281
1,712,641
1,835,990
1,896,886
1,955,063
2,185,719
2,185,7191,955,0631,896,8861,835,9901,712,6411,756,2811,876,2481,661,8501,577,8061,596,5571,578,9501,541,2161,502,2161,525,4661,540,9631,561,4171,622,7751,616,9171,583,272000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
43,858
70,957
73,668
96,696
101,856
114,077
134,030
145,487
150,769
158,682
166,545
165,488
169,613
192,254
197,847
198,816
198,002
241,301
197,526
242,104
196,757
238,511
192,619
244,633
192,840
240,754
224,845
253,755
207,481
283,981
246,089
270,209
230,862
307,113
268,632
307,606
266,755
315,223
269,448
322,781
299,333
350,432
304,507
367,542
316,060
369,595
322,455
440,007
405,542
504,843
498,128
558,119
439,408
454,043
463,994
475,265
482,531
490,774
493,182
498,761
501,074
566,250
643,146
670,051
682,745
697,611
732,959
807,302
800,326
803,649
801,563
780,108
783,849
779,468
770,355
766,039
753,122
755,578
728,689
730,031
724,134
720,785
720,780
732,925
730,693
718,519
705,259
706,764
690,725
675,071
659,548
659,548675,071690,725706,764705,259718,519730,693732,925720,780720,785724,134730,031728,689755,578753,122766,039770,355779,468783,849780,108801,563803,649800,326807,302732,959697,611682,745670,051643,146566,250501,074498,761493,182490,774482,531475,265463,994454,043439,408558,119498,128504,843405,542440,007322,455369,595316,060367,542304,507350,432299,333322,781269,448315,223266,755307,606268,632307,113230,862270,209246,089283,981207,481253,755224,845240,754192,840244,633192,619238,511196,757242,104197,526241,301198,002198,816197,847192,254169,613165,488166,545158,682150,769145,487134,030114,077101,85696,69673,66870,95743,858
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,054
8,054
8,054
8,054
8,054
8,054
8,054
8,054
8,054
8,054
8,054
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
500
0
0
0
0
0
0
0
0
0
0
0
0
0000000000005005005005005005005005005005005005005005005005008,0548,0548,0548,0548,0548,0548,0548,0548,0548,0548,0540000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
307,058
288,418
278,143
319,041
365,994
382,734
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000382,734365,994319,041278,143288,418307,058000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
11,655
13,601
11,115
11,801
11,821
14,598
14,839
11,986
12,136
14,098
14,048
47,230
46,718
52,171
51,618
51,357
53,328
9,268
52,137
16,631
58,424
16,162
58,342
18,122
72,192
25,881
70,128
12,261
65,833
20,464
60,721
14,025
67,963
10,060
68,339
9,114
75,325
9,674
89,326
7,104
98,037
6,704
102,704
8,176
108,766
14,781
113,959
26,919
118,022
24,934
117,616
22,755
128,036
126,610
125,325
123,898
122,475
121,052
119,628
118,329
117,174
333,653
330,841
133,063
158,419
217,982
215,697
266,227
263,642
260,556
253,665
251,311
307,506
87,509
303,340
302,760
300,437
298,342
296,120
282,852
280,353
278,927
276,745
286,353
284,916
262,628
261,292
241,868
241,904
243,251
241,937
241,937243,251241,904241,868261,292262,628284,916286,353276,745278,927280,353282,852296,120298,342300,437302,760303,34087,509307,506251,311253,665260,556263,642266,227215,697217,982158,419133,063330,841333,653117,174118,329119,628121,052122,475123,898125,325126,610128,03622,755117,61624,934118,02226,919113,95914,781108,7668,176102,7046,70498,0377,10489,3269,67475,3259,11468,33910,06067,96314,02560,72120,46465,83312,26170,12825,88172,19218,12258,34216,16258,42416,63152,1379,26853,32851,35751,61852,17146,71847,23014,04814,09812,13611,98614,83914,59811,82111,80111,11513,60111,655
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,304
44,752
43,242
42,483
43,752
45,600
47,509
41,454
43,412
68,590
49,494
145,254
311,944
268,564
249,582
366,560
408,557
502,218
717,176
717,176502,218408,557366,560249,582268,564311,944145,25449,49468,59043,41241,45447,50945,60043,75242,48343,24244,75248,304000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
102,216
106,330
138,527
158,587
135,812
164,098
185,976
281,002
237,407
315,043
294,162
289,647
342,381
375,016
387,190
359,359
398,739
406,913
413,264
392,440
406,900
479,716
436,261
392,028
493,419
411,698
483,203
363,306
405,016
429,451
430,923
418,548
456,437
446,049
429,619
378,516
422,102
479,547
501,444
489,245
558,152
544,070
546,422
524,017
557,877
563,719
600,268
597,356
583,745
586,617
624,464
663,236
712,454
785,009
861,137
913,700
1,007,614
986,957
1,045,119
984,578
1,000,935
942,278
974,654
869,350
1,012,618
1,058,055
1,084,056
1,103,518
1,263,321
1,314,840
1,236,500
1,015,484
1,234,182
1,282,001
1,222,646
1,095,331
1,225,165
1,148,053
1,100,367
1,135,602
1,337,941
1,451,211
1,465,020
1,506,512
1,617,550
1,677,760
1,647,708
1,785,917
1,784,981
1,795,680
1,913,340
1,913,3401,795,6801,784,9811,785,9171,647,7081,677,7601,617,5501,506,5121,465,0201,451,2111,337,9411,135,6021,100,3671,148,0531,225,1651,095,3311,222,6461,282,0011,234,1821,015,4841,236,5001,314,8401,263,3211,103,5181,084,0561,058,0551,012,618869,350974,654942,2781,000,935984,5781,045,119986,9571,007,614913,700861,137785,009712,454663,236624,464586,617583,745597,356600,268563,719557,877524,017546,422544,070558,152489,245501,444479,547422,102378,516429,619446,049456,437418,548430,923429,451405,016363,306483,203411,698493,419392,028436,261479,716406,900392,440413,264406,913398,739359,359387,190375,016342,381289,647294,162315,043237,407281,002185,976164,098135,812158,587138,527106,330102,216
   > Total Current Liabilities 
86,988
64,734
98,687
85,502
63,802
92,966
85,429
196,626
153,907
231,872
211,868
178,195
231,807
265,219
278,122
251,868
292,126
301,287
278,144
256,959
271,420
313,936
326,541
376,259
454,351
380,414
446,224
330,791
375,342
407,880
424,065
412,419
444,859
432,183
416,612
347,374
343,037
398,228
403,738
391,612
463,380
450,602
454,752
427,248
462,195
446,456
484,524
486,850
504,314
505,097
543,616
573,166
648,269
721,916
710,698
758,835
801,410
753,463
868,393
785,182
831,232
778,941
851,608
756,718
898,862
947,712
974,179
1,009,244
1,175,717
1,235,663
1,160,974
942,622
1,156,453
1,192,696
1,134,025
1,013,791
1,145,780
1,074,355
1,028,411
1,066,257
1,252,850
1,376,310
1,389,245
1,437,648
1,546,756
1,608,266
1,578,034
1,711,948
1,705,556
1,718,471
1,838,326
1,838,3261,718,4711,705,5561,711,9481,578,0341,608,2661,546,7561,437,6481,389,2451,376,3101,252,8501,066,2571,028,4111,074,3551,145,7801,013,7911,134,0251,192,6961,156,453942,6221,160,9741,235,6631,175,7171,009,244974,179947,712898,862756,718851,608778,941831,232785,182868,393753,463801,410758,835710,698721,916648,269573,166543,616505,097504,314486,850484,524446,456462,195427,248454,752450,602463,380391,612403,738398,228343,037347,374416,612432,183444,859412,419424,065407,880375,342330,791446,224380,414454,351376,259326,541313,936271,420256,959278,144301,287292,126251,868278,122265,219231,807178,195211,868231,872153,907196,62685,42992,96663,80285,50298,68764,73486,988
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
263,000
265,000
200,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000200,000265,000263,000000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
263,000
265,000
200,000
135,000
235,000
106,511
61,511
20,000
110,000
140,000
100,000
126,338
156,365
163,109
122,002
93,811
81,503
69,617
101,787
101,78769,61781,50393,811122,002163,109156,365126,338100,000140,000110,00020,00061,511106,511235,000135,000200,000265,000263,000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
14,074
13,634
18,188
16,661
11,153
12,382
24,154
34,787
12,198
75,858
80,079
20,416
22,714
31,746
35,046
40,482
41,211
48,786
85,551
80,622
41,324
40,618
42,305
43,401
39,014
50,942
41,525
34,257
25,657
26,487
26,862
28,911
28,295
25,369
20,345
27,347
26,879
28,089
24,964
27,432
30,598
31,130
29,537
44,670
27,989
28,582
29,145
33,685
26,440
24,229
31,362
40,267
35,674
29,336
31,795
54,478
46,614
40,913
47,097
53,199
49,784
44,373
56,927
61,532
51,965
51,450
66,691
85,422
69,241
64,680
62,578
61,784
48,336
47,176
45,030
67,660
53,708
64,665
64,345
78,809
58,497
73,195
84,693
78,011
80,063
64,839
68,172
68,021
73,460
72,884
74,955
74,95572,88473,46068,02168,17264,83980,06378,01184,69373,19558,49778,80964,34564,66553,70867,66045,03047,17648,33661,78462,57864,68069,24185,42266,69151,45051,96561,53256,92744,37349,78453,19947,09740,91346,61454,47831,79529,33635,67440,26731,36224,22926,44033,68529,14528,58227,98944,67029,53731,13030,59827,43224,96428,08926,87927,34720,34525,36928,29528,91126,86226,48725,65734,25741,52550,94239,01443,40142,30540,61841,32480,62285,55148,78641,21140,48235,04631,74622,71420,41680,07975,85812,19834,78724,15412,38211,15316,66118,18813,63414,074
       Other Current Liabilities 
32,777
21,100
17,499
35,841
20,649
25,584
19,275
54,839
46,709
50,464
31,239
29,979
39,293
81,673
72,276
55,886
55,415
69,001
73,093
47,437
41,196
54,418
59,336
58,058
98,037
86,472
120,699
71,034
89,185
105,393
104,803
87,108
98,064
113,414
112,867
106,627
104,758
135,639
144,274
121,680
120,282
136,972
116,715
104,078
105,706
109,374
114,379
112,165
134,874
159,368
160,754
187,399
196,096
276,079
252,902
240,357
316,797
314,549
393,296
351,983
378,948
402,067
490,181
490,686
559,897
489,263
552,489
638,821
773,976
301,330
643,151
208,481
775,915
201,857
802,333
249,280
773,721
217,496
805,213
293,191
971,817
246,299
1,080,013
485,271
1,174,861
368,358
1,255,608
50,834
47,155
474,488
40,923
40,923474,48847,15550,8341,255,608368,3581,174,861485,2711,080,013246,299971,817293,191805,213217,496773,721249,280802,333201,857775,915208,481643,151301,330773,976638,821552,489489,263559,897490,686490,181402,067378,948351,983393,296314,549316,797240,357252,902276,079196,096187,399160,754159,368134,874112,165114,379109,374105,706104,078116,715136,972120,282121,680144,274135,639104,758106,627112,867113,41498,06487,108104,803105,39389,18571,034120,69986,47298,03758,05859,33654,41841,19647,43773,09369,00155,41555,88672,27681,67339,29329,97931,23950,46446,70954,83919,27525,58420,64935,84117,49921,10032,777
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,729
89,306
88,621
81,541
79,385
73,698
71,956
69,345
85,091
74,902
75,775
68,864
70,794
69,494
69,673
73,968
79,425
77,210
75,014
75,01477,21079,42573,96869,67369,49470,79468,86475,77574,90285,09169,34571,95673,69879,38581,54188,62189,30677,729000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-263,000
-265,000
-200,000
0
0
0
0
0
8,431
9,987
10,571
7,904
8,131
7,936
6,375
6,197
6,367
6,193
6,135
6,1356,1936,3676,1976,3757,9368,1317,90410,5719,9878,43100000-200,000-265,000-263,000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
87,428
88,318
94,811
94,346
95,125
95,129
98,045
97,903
97,654
96,422
87,150
86,346
85,842
86,524
65,533
66,446
68,843
69,431
0
0
48,095
0
048,0950069,43168,84366,44665,53386,52485,84286,34687,15096,42297,65497,90398,04595,12995,12594,34694,81188,31887,428000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
72,139
408,464
396,363
401,790
403,523
406,868
412,184
414,873
416,547
421,436
425,843
432,011
433,845
433,816
438,248
440,063
441,996
444,621
449,185
453,511
452,922
452,562
455,605
456,188
506,624
529,065
537,936
559,979
556,494
533,857
531,741
529,892
556,705
583,179
583,153
627,134
641,343
617,013
661,252
691,354
684,560
672,289
665,233
665,604
672,542
677,600
684,246
679,255
892,866
873,285
952,595
967,308
991,614
961,045
1,501,328
1,543,478
1,884,573
1,830,561
1,543,449
1,706,138
1,596,585
2,144,485
2,072,967
2,087,072
2,162,828
2,127,015
2,187,065
2,174,308
2,216,640
2,112,321
2,114,013
2,082,131
2,206,508
2,232,592
2,217,642
2,209,888
2,281,813
2,189,625
2,270,642
2,312,724
2,422,675
2,146,308
2,243,079
2,278,990
2,430,093
2,284,318
2,445,760
2,550,919
2,698,988
2,542,567
2,711,118
2,711,1182,542,5672,698,9882,550,9192,445,7602,284,3182,430,0932,278,9902,243,0792,146,3082,422,6752,312,7242,270,6422,189,6252,281,8132,209,8882,217,6422,232,5922,206,5082,082,1312,114,0132,112,3212,216,6402,174,3082,187,0652,127,0152,162,8282,087,0722,072,9672,144,4851,596,5851,706,1381,543,4491,830,5611,884,5731,543,4781,501,328961,045991,614967,308952,595873,285892,866679,255684,246677,600672,542665,604665,233672,289684,560691,354661,252617,013641,343627,134583,153583,179556,705529,892531,741533,857556,494559,979537,936529,065506,624456,188455,605452,562452,922453,511449,185444,621441,996440,063438,248433,816433,845432,011425,843421,436416,547414,873412,184406,868403,523401,790396,363408,46472,139
   Common Stock
60,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
100,360
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
200,720
229,058
343,587
357,267
357,267
357,267
357,267
535,563
535,563
535,563
535,482
535,482
535,482
535,482
592,368
592,321
592,321
592,321
592,321
592,321
592,321
592,321
592,321
586,449
586,449
586,449
586,449
586,449
567,809
567,809
567,809
567,809
567,809
567,809
567,809
567,809
567,759
567,459
567,459
567,459
0
0
567,300
0
0567,30000567,459567,459567,459567,759567,809567,809567,809567,809567,809567,809567,809567,809586,449586,449586,449586,449586,449592,321592,321592,321592,321592,321592,321592,321592,321592,368535,482535,482535,482535,482535,563535,563535,563357,267357,267357,267357,267343,587229,058200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720200,720100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,360100,36060,360
   Retained Earnings 
10,056
22,145
11,801
13,461
15,194
18,472
23,789
24,483
26,157
31,046
35,453
36,532
38,366
37,660
42,093
41,540
43,473
46,098
50,662
52,218
53,629
54,593
57,756
57,208
80,488
102,914
99,992
118,758
119,947
118,391
119,377
116,685
123,839
137,155
141,438
143,399
154,892
149,902
158,015
177,878
187,049
181,671
194,383
194,461
206,518
183,446
197,036
201,943
268,761
258,435
272,041
274,185
347,494
312,749
335,503
349,533
391,234
399,291
424,590
449,889
501,166
549,385
700,592
695,135
763,814
740,287
796,655
823,399
897,735
881,229
947,327
977,814
924,174
919,696
997,996
1,185,270
1,261,804
1,192,302
1,284,497
1,340,416
1,437,836
1,339,435
1,446,505
1,481,315
1,612,089
1,469,707
1,604,534
1,380,683
1,524,930
1,643,045
1,508,409
1,508,4091,643,0451,524,9301,380,6831,604,5341,469,7071,612,0891,481,3151,446,5051,339,4351,437,8361,340,4161,284,4971,192,3021,261,8041,185,270997,996919,696924,174977,814947,327881,229897,735823,399796,655740,287763,814695,135700,592549,385501,166449,889424,590399,291391,234349,533335,503312,749347,494274,185272,041258,435268,761201,943197,036183,446206,518194,461194,383181,671187,049177,878158,015149,902154,892143,399141,438137,155123,839116,685119,377118,391119,947118,75899,992102,91480,48857,20857,75654,59353,62952,21850,66246,09843,47341,54042,09337,66038,36636,53235,45331,04626,15724,48323,78918,47215,19413,46111,80122,14510,056
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
120,200
106,430
82,061
117,459
158,223
157,662
117,290
112,681
89,994
78,816
98,306
122,616
74,117
69,240
56,083
67,241
54,134
46,410
0
0
76,552
0
076,5520046,41054,13467,24156,08369,24074,117122,61698,30678,81689,994112,681117,290157,662158,223117,45982,061106,430120,200000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,231,619
Cost of Revenue-858,841
Gross Profit2,372,7782,372,778
 
Operating Income (+$)
Gross Profit2,372,778
Operating Expense-2,677,127
Operating Income554,491-304,349
 
Operating Expense (+$)
Research Development123,330
Selling General Administrative1,543,450
Selling And Marketing Expenses-
Operating Expense2,677,1271,666,780
 
Net Interest Income (+$)
Interest Income23,584
Interest Expense-2,807
Other Finance Cost-13,423
Net Interest Income34,200
 
Pretax Income (+$)
Operating Income554,491
Net Interest Income34,200
Other Non-Operating Income Expenses-
Income Before Tax (EBT)598,210554,491
EBIT - interestExpense = -2,807
526,168
528,975
Interest Expense2,807
Earnings Before Interest and Taxes (EBIT)-601,017
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax598,210
Tax Provision-72,108
Net Income From Continuing Ops526,102526,102
Net Income526,168
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--34,200
 

Technical Analysis of Lingrui
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lingrui. The general trend of Lingrui is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lingrui's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Henan Lingrui Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 21.73.

The bearish price targets are: 19.96 > 19.85 > 18.27.

Tweet this
Henan Lingrui Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Henan Lingrui Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Henan Lingrui Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Henan Lingrui Pharmaceutical Co Ltd. The current macd is 0.49026354.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lingrui price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Lingrui. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Lingrui price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Henan Lingrui Pharmaceutical Co Ltd. The current adx is 33.94.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lingrui shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Henan Lingrui Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Henan Lingrui Pharmaceutical Co Ltd. The current sar is 20.04.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Henan Lingrui Pharmaceutical Co Ltd. The current rsi is 62.27. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Henan Lingrui Pharmaceutical Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lingrui price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartHenan Lingrui Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Henan Lingrui Pharmaceutical Co Ltd. The current cci is 85.78.

Henan Lingrui Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Henan Lingrui Pharmaceutical Co Ltd. The current cmo is 27.40.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Henan Lingrui Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Henan Lingrui Pharmaceutical Co Ltd. The current willr is -22.35294118.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lingrui is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Henan Lingrui Pharmaceutical Co Ltd Daily Williams %R ChartHenan Lingrui Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Henan Lingrui Pharmaceutical Co Ltd.

Henan Lingrui Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Henan Lingrui Pharmaceutical Co Ltd. The current atr is 0.7240703.

Henan Lingrui Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Henan Lingrui Pharmaceutical Co Ltd. The current obv is 407,754,521.

Henan Lingrui Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartHenan Lingrui Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Henan Lingrui Pharmaceutical Co Ltd. The current mfi is 47.98.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Henan Lingrui Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartHenan Lingrui Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Henan Lingrui Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Henan Lingrui Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Henan Lingrui Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.271
Ma 20Greater thanMa 5020.846
Ma 50Greater thanMa 10019.143
Ma 100Greater thanMa 20017.981
OpenGreater thanClose20.860
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lingrui with someone you think should read this too:
  • Are you bullish or bearish on Lingrui? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lingrui? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Henan Lingrui Pharmaceutical Co Ltd

I send you an email if I find something interesting about Henan Lingrui Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Henan Lingrui Pharmaceutical Co Ltd.

Receive notifications about Henan Lingrui Pharmaceutical Co Ltd in your mailbox!